Literature DB >> 10227710

In situ determination of delavirdine mesylate particle size in solid oral dosage forms.

J G White1.   

Abstract

PURPOSE: The in-situ particle size of delavirdine mesylate in dry mix and tablets was determined.
METHODS: Optical microscopy and fluorescence microscopy combined with image analysis were used for qualitative and quantitative measurements.
RESULTS: Using optical microscopy, it was demonstrated qualitatively that fragmentation of the large drug particles was occurring during tablet compression. Quantitative comparisons between dry mix and tablet samples showed that in the dry mix, drug particles remain intact, with particle lengths exceeding 200 microm. In the tablets, no particles longer than 100 microm had been observed. Analysis of multiple tablet lots revealed consistent in-situ drug particle size distributions, regardless of the original bulk drug particle size.
CONCLUSIONS: Bulk drug particle size of delavirdine mesylate is not predictive of the particle size in the tablet due to fragmentation of particles during compression. Optical and fluorescence microscopy are valuable tools for probing in-situ particle size in complex matrices.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227710     DOI: 10.1023/a:1018875130152

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  6 in total

1.  Effect of compaction on particle size.

Authors:  K A Khan; C T Rhodes
Journal:  J Pharm Sci       Date:  1975-03       Impact factor: 3.534

2.  Laser diffraction estimation of particle size distribution of slightly water-soluble drugs coexisting with additives: application to solid dosage forms.

Authors:  Y Nishioka; T Ohsawa; M Kobayashi; K Noda
Journal:  Chem Pharm Bull (Tokyo)       Date:  1992-06       Impact factor: 1.645

3.  Evaluation of changes in drug particle size during tableting by measurement of dissolution of disintegrated tablets.

Authors:  N Kitamori; T Makino
Journal:  J Pharm Pharmacol       Date:  1979-08       Impact factor: 3.765

4.  Effect of drug content and drug particle size on the change in particle size during tablet compression.

Authors:  N Kitamori; T Makino
Journal:  J Pharm Pharmacol       Date:  1979-08       Impact factor: 3.765

5.  Interpretation of dissolution rate maxima: dependence upon tablet compression force.

Authors:  H L Smith; C A Baker; J H Wood
Journal:  J Pharm Pharmacol       Date:  1971-07       Impact factor: 3.765

6.  The effect of particle fragmentation and deformation on the interparticulate bond formation process during powder compaction.

Authors:  M Eriksson; G Alderborn
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.